Back To: Home : Featured Technology : Gene and Cell Therapies

CLICK HERE FOR WHAT'S NEW IN:
 

Edit-R CRISPRa reagent platform for genome-wide CRISPR activation
March 2018
SHARING OPTIONS:

Horizon Discovery/Dharmacon
 
Horizon Discovery, a global leader in gene editing and gene modulation technologies, recently announced the launch of its reagent platform for CRISPR activation (CRISPRa) from its recently acquired Dharmacon business. This is the latest addition to the company’s market-leading Edit-R portfolio for CRISPR-Cas9 genome engineering.
 
Horizon Discovery
Product link

Back


PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.